Clinical Trials Using Anti-PD-1/Anti-TGFbRII Bispecific Antibody INCA33890
Review the clinical trials studying anti-pd-1/anti-tgfbrii bispecific antibody inca33890 on this list and use the filters to refine the results by age and location. Some clinical trials are held at NCI-Designated Cancer Centers and may be supported by other organizations.
You can find more information about the types and phases of clinical trials and what to expect or use our Steps to Find a Clinical Trial.
Trials 1-1 of
1
- A Study to Evaluate the Safety of INCA33890 in Participants With Advanced or Metastatic Solid TumorsStatus: ActiveLocation: 4 locations